Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Directorate of Pharmacy and Medical Stores, Khawlah Hospital, Muscat, Oman.
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):777-786. doi: 10.1080/14787210.2023.2224961. Epub 2023 Jun 23.
This study was aimed to explore thresholds with interaction effects among antibiotic usage, covariates (alcohol-based hand rub (ABHR)), and their effect on extended-spectrum β-lactamase-producing Klebsiella pneumoniae (ESBL-producing K. pneumoniae) in hospitalized patients.
Multivariate Adaptive Regression Spline models were used. These considered second-order interactions among antibiotic use and ABHR in addition to potential thresholds that further improve explained variance in the ESBL-producing K. pneumoniae response. The study involved collecting monthly hospital-level data for January 2017-December 2021.
Analysis of the main effects showed that third-generation cephalosporins above 2.00 DDD/100 occupied bed days (OBD) generally increased ESBL-producing K. pneumoniae incidence (cases/100 OBD). Levels of ABHR above 6.61 L/100 OBD were shown to generally decrease ESBL-producing K. pneumoniae incidence. Second-order interactions revealed that when third-generation cephalosporin use was greater than 3.71 DDD/100 OBD, and ABHR was greater than 6.6 L/100 OBD (same as main effect threshold), ABHR partially lost effectiveness in its ability to reduce ESBL-producing K. pneumoniae incidence. This demonstrates the importance of not exceeding the identified thresholds of 3.71 DDD/100 OBD for third-generation cephalosporin use.
The main-effect thresholds in third-generation cephalosporins and ABHR, and the identified interaction between third-generation cephalosporins and ABHR can inform effective hospital antimicrobial stewardship.
本研究旨在探索抗生素使用、协变量(酒精基洗手液(ABHR))及其对住院患者中产超广谱β-内酰胺酶肺炎克雷伯菌(ESBL 产肺炎克雷伯菌)的影响之间的交互作用阈值。
使用多变量自适应回归样条模型。这些模型考虑了抗生素使用和 ABHR 之间的二阶相互作用,以及进一步提高 ESBL 产肺炎克雷伯菌反应解释方差的潜在阈值。该研究涉及收集 2017 年 1 月至 2021 年 12 月的每月医院层面数据。
主要效应分析表明,第三代头孢菌素用量超过 2.00 DDD/100 占用床日(OBD)通常会增加 ESBL 产肺炎克雷伯菌的发病率(每 100 OBD 病例数)。ABHR 水平超过 6.61 L/100 OBD 通常会降低 ESBL 产肺炎克雷伯菌的发病率。二阶相互作用表明,当第三代头孢菌素的使用量大于 3.71 DDD/100 OBD,且 ABHR 大于 6.6 L/100 OBD(与主要效应阈值相同)时,ABHR 在降低 ESBL 产肺炎克雷伯菌发病率方面的有效性会部分丧失。这表明超过 3.71 DDD/100 OBD 第三代头孢菌素使用量的确定阈值非常重要。
第三代头孢菌素和 ABHR 的主要效应阈值,以及第三代头孢菌素和 ABHR 之间确定的相互作用,可以为有效的医院抗菌药物管理提供信息。